Living with hypophosphatemia

Stories from people navigating hypophosphatemia — diagnosis, treatment, caregiving, and the ordinary days in between.

3 stories

Intravenous iron infusion supplies beside a laboratory tube labeled for serum phosphate testing.

Endocrinology & Metabolism

Ferric Carboxymaltose Gets Boxed Warning for Low Phosphate

The FDA has elevated the hypophosphatemia warning for ferric carboxymaltose, affecting iron selection, patient counseling and phosphate evaluation.

Rayan Salih · November 5, 2026 · 6 min

Intravenous iron vial beside a laboratory phosphate result and infusion supplies on a clinical work surface.

Endocrinology & Metabolism

Ferric Carboxymaltose Boxed Warning Elevates Phosphate Risk

The FDA boxed warning highlights serious hypophosphatemia with ferric carboxymaltose, particularly after repeated exposure. Treatment selection should now include phosphate risk, counseling and monitoring needs.

Dr. Abu Bakar · 7 min read

An intravenous iron vial beside a laboratory phosphate result and clinical monitoring notes.

Endocrinology & Metabolism

FDA Adds Boxed Warning for Symptomatic Hypophosphatemia With Ferric Carboxymaltose

The FDA boxed warning makes hypophosphatemia a central consideration when ferric carboxymaltose is selected, particularly for patients with risk factors or repeated exposure.

Dr. Abu Bakar · 6 min read

Other conditions

One story a day

The story of the day, in your inbox

One health journey each morning — no advice, no alarm, just company for the road.